673 Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II study

Autor:	Xiaohua Wu, Lingfang Xia, Jing Wang, Chunyan Wang, Qingming Zhang, Jianqing Zhu, Qunxian Rao, Huijun Cheng, Zheng Liu, Yongmei Yin, Xiaohong Ai, Kurban Gulina, Hong Zheng, Xiaoyong Luo, Baoping Chang, Li Li, Haiyan Liu, Yunxia Li, Ge Lou, Qi Zhou, Yanling Zhu, Zemin Xiao, Jiandong Tong, Ke Wang, Jie Chen, Xia Wang, Lijie Song, Zhixia Wei, Yijing Ye, Jiman Zhu
Rok vydání:	2022
Zdroj:	Regular and Young Investigator Award Abstracts.
DOI:	10.1136/jitc-2022-sitc2022.0673
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8219d4ef8a926c4889bf53891d96e856 https://doi.org/10.1136/jitc-2022-sitc2022.0673 Zobrazit plný text záznamu